|
1
|
Tsai SC, Lu CC, Bau DT, Chiu YJ, Yen YT, Hsu YM, Fu CW, Kuo SC, Lo YS, Chiu HY, et al: Approaches towards fighting the COVID-19 pandemic (review). Int J Mol Med. 47:3–22. 2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Pandey V and Singh A, Siddiqui S, Raikwar A, Gond AK, Ali S, Yadav M, Datta A and Singh A: COVID-19: An update of current knowledge (Review). World Acad Sci J. 3(1)2021.
|
|
3
|
Chen C, Guan Y, Wei J, Zhou Y, Yao W, Li X and Hei Z: Restricting activity and earlier oxygen supplementation may reduce adverse outcomes in patients with COVID-19 (Review). World Acad Sci J. 3(1)2021.
|
|
4
|
Alberca RW, Lima JC, de Oliveira EA, Gozzi-Silva SC, Ramos YÁ, Andrade MM, Beserra DR, Oliveira LM, Branco AC, Pietrobon AJ, et al: COVID-19 disease course in former smokers, smokers and COPD patients. Front Physiol. 11(637627)2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Leung JM, Yang CX, Tam A, Shaipanich T, Hackett TL, Singhera GK, Dorscheid DR and Sin DD: ACE-2 expression in the small airway epithelia of smokers and COPD patients: Implications for COVID-19. Eur Respir J. 55(2000688)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Vardavas CI and Nikitara K: COVID-19 and smoking: A systematic review of the evidence. Tob Induc Dis. 18(20)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Alberca RW, Rigato PO, Ramos YÁL, Teixeira FME, Castelo Branco ACC, Fernandes IG, Pietrobon AJ, Duarte AJDS, Aoki V, Orfali RL and Sato MN: Clinical characteristics and survival analysis in frequent alcohol consumers with COVID-19. Front Nutr. 8(689296)2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lai CC, Wang CY and Hsueh PR: Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect. 53:505–512. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Alberca R, Aoki V and Sato M: COVID-19 and HIV: Case reports of 2 co-infected patients with different disease courses. World Acad Sci J. 3(4)2020.
|
|
10
|
Barron E, Bakhai C, Kar P, Weaver A, Bradley D, Ismail H, Knighton P, Holman N, Khunti K, Sattar N, et al: Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: A whole-population study. Lancet Diabetes Endocrinol. 8:813–822. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Codo AC, Davanzo GG, Monteiro LB, de Souza GF, Muraro SP, Virgilio-da-Silva JV, Prodonoff JS, Carregari VC, de Biagi Junior CAO, Crunfli F, et al: Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis-dependent axis. Cell Metab. 32:437–446.e5. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Alberca RW, Oliveira LM, Branco AC, Pereira NZ and Sato MN: Obesity as a risk factor for COVID-19: An overview. Crit Rev Food Sci Nutr. 61:2262–2276. 2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Liu K, Chen Y, Lin R and Han K: Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. J Infect. 80:e14–e18. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Perrotta F, Corbi G, Mazzeo G, Boccia M, Aronne L, D'Agnano V, Komici K, Mazzarella G, Parrella R and Bianco A: COVID-19 and the elderly: Insights into pathogenesis and clinical decision-making. Aging Clin Exp Res. 32:1599–1608. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Minniti CP, Zaidi AU, Nouraie M, Manwani D, Crouch GD, Crouch AS, Callaghan MU, Carpenter S, Jacobs C, Han J, et al: Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection. Blood Adv. 5:207–215. 2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Arlet JB, de Luna G, Khimoud D, Odièvre MH, de Montalembert M, Joseph L, Chantalat-Auger C, Flamarion E, Bartolucci P, Lionnet F, et al: Prognosis of patients with sickle cell disease and COVID-19: A French experience. Lancet Haematol. 7:e632–e634. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ware RE, de Montalembert M, Tshilolo L and Abboud MR: Sickle cell disease. Lancet. 390:311–323. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yue L, Lin M, Chen JT, Zhan XF, Zhong DS, Monte-Nguba SM, Liu PF, Pan XF, Huang JH, Wang X, et al: Rapid screening for sickle cell disease by polymerase chain reaction-high resolution melting analysis. Mol Med Rep. 9:2479–2484. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhang X, Li C and Li Q: Magnetic resonance imaging in pediatric sickle cell anemia. Exp Ther Med. 12:555–558. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Berzuini A, Bianco C, Migliorini AC, Maggioni M, Valenti L and Prati D: Red blood cell morphology in patients with COVID-19-related anaemia. Blood Transfus. 19:34–36. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, Psaltopoulou T, Gerotziafas G and Dimopoulos MA: Hematological findings and complications of COVID-19. Am J Hematol. 95:834–847. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ye J, Jiao Y, Zhang Y, Li Z, Zeng X, Deng H and Yang M: Hematological changes in patients with COVID-19 (review). Mol Med Rep. 22:4485–4491. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Alberca RW, Yendo TM, Leuzzi Ramos YÁ, Fernandes IG, Oliveira LM, Teixeira FM, Beserra DR, de Oliveira EA, Gozzi-Silva SC, Andrade MM, et al: Case Report: COVID-19 and chagas disease in two coinfected patients. Am J Trop Med Hyg. 103:2353–2356. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Netea MG, Giamarellos-Bourboulis EJ, Domínguez-Andrés J, Curtis N, van Crevel R, van de Veerdonk FL and Bonten M: Trained immunity: A tool for reducing susceptibility to and the severity of SARS-CoV-2 infection. Cell. 181:969–977. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Vasarmidi E, Tsitoura E, Spandidos D, Tzanakis N and Antoniou K: Pulmonary fibrosis in the aftermath of the Covid-19 era (review). Exp Ther Med. 20:2557–2560. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Brünink S, Schneider J, Schmidt ML, et al: Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 25(2000045)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Singh AK, Jena A, Kumar-M P, Sharma V and Sebastian S: Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta-analysis. United European Gastroenterol J. 9:159–176. 2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA and Gao YD: Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 75:1730–1741. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Panepintoa JA, Brandow A, Mucalo L, Yusuf F, Singh A, Taylor B, Woods K, Payne AB, Peacock G and Schieve LA: Coronavirus disease among persons with sickle cell disease, United States, March 20-May 21, 2020. Emerg Infect Dis. 26:2473–2476. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 395:497–506. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, Liu L, Shan H, Lei C, Hui DSC, et al: Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 382:1708–1720. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Abdulrahman A, Wael M, AlAmmadi F, Almosawi Z, Alsherooqi R, Abduljalil M, Kumar N and AlQahtani M: Is sickle cell disease a risk factor for severe COVID-19 outcomes in hospitalized patients? A multicenter national retrospective cohort study. eJHaem. 2:167–174. 2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Azerad MA, Bayoudh F, Weber T, Minon JM, Ketelslegers O, Hoyoux M, Ren X, Azerad MA, Bayoudh F, Weber T, et al: Sickle cell disease and COVID-19: Atypical presentations and favorable outcomes. eJHaem. 1:338–341. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Singh A, Brandow AM and Panepinto JA: COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals. Blood Adv. 5:1915–1921. 2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Alkindi S, Elsadek RA, Al-Madhani A, Al-Musalhi M, AlKindi SY, Al-Khadouri G, Al Rawahi B, Al-Ruqeishi S, Al-Yazeedi J, Wali YA, et al: Impact of COVID-19 on vasooclusive crisis in patients with sickle cell anaemia. Int J Infect Dis. 106:128–133. 2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Gladwin MT: Cardiovascular complications in patients with sickle cell disease. Hematology Am Soc Hematol Educ Program. 2017:423–430. 2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Rees DC, Williams TN and Gladwin MT: Sickle-cell disease. Lancet. 376:2018–2031. 2010.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Piel FB, Steinberg MH and Rees DC: Sickle cell disease. N Engl J Med. 376:1561–1573. 2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Petito E, Falcinelli E, Paliani U, Cesari E, Vaudo G, Sebastiano M, Cerotto V, Guglielmini G, Gori F, Malvestiti M, et al: Association of neutrophil activation, more than platelet activation, with thrombotic complications in coronavirus disease 2019. J Infect Dis. 223:933–944. 2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Vingert B, Tamagne M, Desmarets M, Pakdaman S, Elayeb R, Habibi A, Bernaudin F, Galacteros F, Bierling P, Noizat-Pirenne F and Cohen JL: Partial dysfunction of Treg activation in sickle cell disease. Am J Hematol. 89:261–266. 2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, Xie C, Ma K, Shang K, Wang W and Tian DS: Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 71:762–768. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Chakravorty S, Padmore-Payne G, Ike F, Tshibangu V, Graham C, Rees D and Stuart-Smith S: COVID-19 in patients with sickle cell disease-a case series from a UK tertiary hospital. Haematologica. 105:2691–2693. 2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Raveendran AV, Jayadevan R and Sashidharan S: Long COVID: An overview. Diabetes Metab Syndr. 15:869–875. 2021.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Zhang NH, Cheng YC, Luo R, Zhang CX, Ge SW and Xu G: Recovery of new-onset kidney disease in COVID-19 patients discharged from hospital. BMC Infect Dis. 21(397)2021.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Townsend L, Fogarty H, Dyer A, Martin-Loeches I, Bannan C, Nadarajan P, Bergin C, O'Farrelly C, Conlon N, Bourke NM, et al: Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. J Thromb Haemost. 19:1064–1070. 2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Galeotti C and Bayry J: Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol. 16:413–414. 2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Jurado RL: Iron, infections, and anemia of inflammation. Clin Infect Dis. 25:888–895. 1997.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Demir NA, Basturk A, Ural O, Sumer S, Erdogdu B, Kiratli HE, Celik JB, Koplay M and Vatansev H: A case of Evans syndrome secondary to COVID-19. Blood Transfus. 19:85–88. 2021.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, et al: Clinical and immunologic features in severe and moderate forms of coronavirus disease 2019. medRxiv: Feb 19, 2020 (Epub ahead of print). doi: 10.1101/2020.02.16.20023903.
|
|
50
|
Dar J, Mughal I, Hassan H, Al Mekki TE, Chapunduka Z and Hassan ISA: Raised D-dimer levels in acute sickle cell crisis and their correlation with chest X-ray abnormalities. Ger Med Sci. 8(Doc25)2010.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Kubánková M, Hohberger B, Hoffmanns J, Fürst J, Herrmann M, Guck J and Kräter M: Physical phenotype of blood cells is altered in COVID-19. bioRxiv: 2021.02.12.429482, 2021.
|
